Sharekhan's research report on Mastek
Stock has fallen significantly following a muted Q3 and uncertainties on US Fed rate cuts and possible escalation of tariff wars, offering decent entry point from medium to long-term perspective. Mastek has secured ~$85 million in multiple contracts from a UK public service department to boost Digital, Data and Technology services over two years continuing to leverage its expertise in GovTech services. Company is seeing increased traction in UK driven by government services, healthcare, and private sector.
Outlook
We reiterate Buy with revised PT of Rs 3,030. At CMP, the stock trades at 20.4/18.3/15.7x its FY25/26/27E EPS.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
